LeMaitre Vascular
LMAT
$56.20
Share price
-1.39%
Change (1 day)
4.57%
Change (1 year)
Categories
Revenue for LeMaitre Vascular (LMAT)
Revenue in 2023 (TTM): $0.17 B
According to LeMaitre Vascular's latest financial reports the company's current revenue (TTM) is $0.17 B. In 2022 the company made a revenue of $0.16 B an increase over the years 2021 revenue that were of $0.15 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for LeMaitre Vascular from 2004 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $0.17 B | 9.6% |
| 2022 | $0.16 B | 4.68% |
| 2021 | $0.15 B | 19.37% |
| 2020 | $0.12 B | 10.35% |
| 2019 | $0.11 B | 11.05% |
| 2018 | $0.10 B | 4.66% |
| 2017 | $0.10 B | 13.14% |
| 2016 | $89.15 M | 13.78% |
| 2015 | $78.35 M | 10.2% |
| 2014 | $71.09 M | 10.14% |
| 2013 | $64.54 M | 13.77% |
| 2012 | $56.73 M | -1.65% |
| 2011 | $57.68 M | 2.9% |
| 2010 | $56.06 M | 10.12% |
| 2009 | $50.9 M | 4.49% |
| 2008 | $48.72 M | 17.55% |
| 2007 | $41.44 M | 19.69% |
| 2006 | $34.62 M | 12.7% |
| 2005 | $30.72 M | 17.35% |
| 2004 | $26.18 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Baxter BAX | $15.01 B | 8,375.38% | 🇺🇸 USA |
 Boston Scientific BSX | $13.40 B | 7,463.27% | 🇺🇸 USA |
 Edwards Lifesciences EW | $5.65 B | 3,093.00% | 🇺🇸 USA |
 Teleflex TFX | $2.89 B | 1,536.25% | 🇺🇸 USA |
 AngioDynamics ANGO | $0.33 B | 91.20% | 🇺🇸 USA |
 Cardiovascular Systems CSII | $0.23 B | 35.37% | 🇺🇸 USA |